Gastric Bypass is a Cost-Saving Procedure: Results from a Comprehensive Markov Model

• Published in: Obesity surgery 2013-04, Vol.23 (4), p.460-466
• Main Authors: Faria, Gil R., Preto, John R., Costa-Maia, José
• Format: Article
• Language: English
• Subjects: Adult; Body Mass Index; Comorbidity; Cost analysis; Cost-Benefit Analysis; Diabetes; Diabetes Mellitus, Type 2 - economics; Diabetes Mellitus, Type 2 - surgery; Economic Aspects; Female; Gastric Bypass - economics; Gastrointestinal surgery; Gastroplasty - economics; Health care expenditures; Health Expenditures; Humans; Male; Markov Chains; Medicine; Medicine & Public Health; Models, Economic; Monte Carlo simulation; Mortality; Obesity; Obesity, Morbid - economics; Obesity, Morbid - surgery; Patients; Portugal; Public health; Quality-Adjusted Life Years; Surgery; Weight control
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1007/s11695-012-0816-8

Background Obesity is a growing public health problem in industrialized countries and is directly and indirectly responsible for almost 10 % of all health expenditures. Bariatric surgery is the best available treatment, however, associated with important economical expenditures. So, cost-effectiveness analysis of the available surgical options is paramount. Methods We developed a Markov model for three different strategies: best medical management, gastric band, and gastric bypass. The Markov model was constructed to allow for the evaluation of the impact of several obesity-related comorbidities. The results were derived for a representative population of morbidly obese patients, and subgroup analyses were performed for patients without comorbidities, patients with diabetes mellitus, different age, and body mass index (BMI) groups. Cost-effectiveness analysis was performed accounting for lifetime costs and from a societal perspective. Results Gastric bypass is a dominant strategy, rendering a significant decrease in lifetime costs and increase in quality-adjusted life years (QALYs). Comparing with the best medical management, in the global population of patients with a BMI of >35 kg/m 2 , gastric bypass renders 1.9 extra QALYs and saves on average 13,244€ per patient. Younger patients, patients with a BMI between 40 and 50 kg/m 2 , and patients without obesity-related diseases are the ones with a bigger benefit in terms of cost effectiveness. Conclusions Gastric bypass surgery increases quality-adjusted survival and saves resources to health systems. As such, it can be an important process to control the ever-increasing health expenditure.